Artificial Intelligence (AI) In Precision Therapies Market - Forecasts from 2024 to 2029

Artificial intelligence (AI) in the precision therapies market is expected to grow at a CAGR of 27.56%, reaching a market size of US$7.506 billion in 2029 and US$2.223 billion in 2024.

AI in the precision therapies market is a unique and disruptive method that is revolutionizing personalized medicine and patient care. Custom-made medication aims to tailor medical treatments to individual patients' genetics, way of life, and disease characteristics to achieve the best results with the least side complications. Within this field, the application of AI technology has become much faster in exploring potential biomarkers, targets for drug action, options for treatment, and inefficient data management and stratification of patients. Suitable AI techniques can handle large volumes of patient records, genetic information, and outcomes from clinical trials, thus assisting healthcare providers in administering their patients with targeted medications and therapies.

The market of AI in precision therapies is considerably promising in that it could reshape the healthcare sector into more effective and patient-oriented therapies.

Artificial intelligence (AI) in the precision therapies market drivers?

• Rising trends in personalized and precision medicine are increasing the Artificial Intelligence (AI) in precision therapies market growth.

AI technologies employed in precision therapies are rising due to changes in personalized and precision medicine. These changes stress the importance of customizing medical interventions to different patients who have varying genetic makeups, lifestyles, and disease characteristics. New technologies and molecular biology have made identifying various biomarkers and therapeutic targets possible, making treatment more accurate and specific. AI is pivotal in predicting treatment responses and disease outcomes through extensive datasets such as genomes, clinical data, and real-time patient information. The growing emphasis on the effectiveness of personalized or precision medicine in promoting positive patient outcomes has led to increased uptake of AI-based systems in precision therapeutics.

Artificial intelligence (AI) in the precision therapies market - geographical outlook

• North America is witnessing exponential growth during the forecast period

The US has led the research, development, and use of AI technology in precision medicine and therapeutics. It is not surprising that North America leads due to its well-established healthcare facilities, high-level AI funding, and large-scale pharmaceutical and biotech companies. In addition, the region's general trend towards personalized medicine and precision healthcare has created a market for AI-infused solutions that enhance treatment and patient outcomes. Advances in AI technologies will ensure that North America remains the largest shareholder in AI in the precision therapies market.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2029
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) in precision therapies market is segmented and analyzed as follows:

By Therapy Type

• Personalized Medicine
• Targeted Therapies
• Gene Therapies
• Cell Therapies
• Immunotherapies
• Others

By Application

• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Rare Diseases
• Autoimmune Diseases
• Others

By End-User Industry

• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Research Institutes And Academic Centers
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others